The Effectiveness of Botulinum Toxin Injections to Treat Post-Stroke Arm Dysfunction
DOI:
https://doi.org/10.47611/jsrhs.v12i4.5146Keywords:
stroke, botulinum toxin, arm dysfunction, spasticity, post-stroke treatmentAbstract
This review was written to determine the effectiveness of Botulinum Toxin (BoNT) as a treatment for upper extremity dysfunction in post-stroke patients. As most patients survive a stroke, many are burdened with disability and impaired limb function. Seventy percent of stroke patients experience motor dysfunction in the arm, with thirty percent of patients suffering from upper extremity spasticity. Spasticity is a speed-dependent condition where certain muscles are abnormally stiff, resulting in involuntary contraction when the spastic muscle is used. BoNT treatment includes injections in localized muscles and is primarily used to treat spasticity by temporarily paralyzing the injected muscle. Seven systematic reviews/meta-analyses and ten randomized-controlled trials were used to determine the effectiveness of BoNT in post-stroke patients. Overall, BoNT is effective in reducing spasticity and may be effective in reducing pain. However, its ability to improve motor function is still unclear. In addition, there is mixed evidence on the most effective way to administer BoNT treatment, such as the proper dosage or combining BoNT with another therapy. The treatment’s effectiveness is well documented in the chronic stage of stroke but less so in the acute and subacute stages. More research is needed to determine the potential adverse effects of long-term exposure to BoNT and the most appropriate dose to administer.
Downloads
References or Bibliography
Barthels, D., & Das, H. (2020). Current advances in ischemic stroke research and therapies. Biochimica et Biophysica Acta. Molecular Basis of Disease, 1866(4), 165260. https://doi.org/10.1016/j.bbadis.2018.09.012
Langhorne, P., Coupar, F., & Pollock, A. (2009). Motor recovery after stroke: a systematic review. The Lancet. Neurology, 8(8), 741–754. https://doi.org/10.1016/S1474-4422(09)70150-4
Allison, R., Shenton, L., Bamforth, K., Kilbride, C., & Richards, D. (2016). Incidence, Time Course and Predictors of Impairments Relating to Caring for the Profoundly Affected arm After Stroke: A Systematic Review. Physiotherapy Research International, 21(4). https://doi.org/10.1002/pri.1634
Kantak, S., Jax, S., & Wittenberg, G. (2017). Bimanual coordination: A missing piece of arm rehabilitation after stroke. Restorative Neurology and Neuroscience, 35(4), 347–364. https://doi.org/10.3233/RNN-170737
Thibaut, A., Chatelle, C., Ziegler, E., Bruno, M. A., Laureys, S., & Gosseries, O. (2013). Spasticity after stroke: Physiology, assessment and treatment. In Brain Injury (Vol. 27, Issue 10). https://doi.org/10.3109/02699052.2013.804202
Doan, Q. v, Brashear, A., Gillard, P. J., Varon, S. F., Vandenburgh, A. M., Turkel, C. C., & Elovic, E. P. (2012). Relationship between disability and health-related quality of life and caregiver burden in patients with upper limb poststroke spasticity. PM & R : The Journal of Injury, Function, and Rehabilitation, 4(1), 4–10. https://doi.org/10.1016/j.pmrj.2011.10.001
Brown, P. (1994). Pathophysiology of spasticity. Journal of Neurology, Neurosurgery, and Psychiatry, 57(7), 773–777. https://doi.org/10.1136/jnnp.57.7.773
Elovic, E. P., Esquenazi, A., Alter, K. E., Lin, J. L., Alfaro, A., & Kaelin, D. L. (2009). Chemodenervation and nerve blocks in the diagnosis and management of spasticity and muscle overactivity. PM & R : The Journal of Injury, Function, and Rehabilitation, 1(9), 842–851. https://doi.org/10.1016/j.pmrj.2009.08.001
Baricich, A., Picelli, A., Santamato, A., Carda, S., de Sire, A., Smania, N., Cisari, C., & Invernizzi, M. (2018). Safety Profile of High-Dose Botulinum Toxin Type A in Post-Stroke Spasticity Treatment. Clinical Drug Investigation, 38(11), 991–1000. https://doi.org/10.1007/s40261-018-0701-x
Escaldi, S. (2018). Neurolysis: A Brief Review for a Fading Art. Physical Medicine and Rehabilitation Clinics of North America, 29(3), 519–527. https://doi.org/10.1016/j.pmr.2018.03.005
Nigam, P., & Nigam, A. (2010). Botulinum toxin. Indian Journal of Dermatology, 55(1), 8. https://doi.org/10.4103/0019-5154.60343
van Kuijk, A. A., Geurts, A. C. H., Bevaart, B. J. W., & van Limbeek, J. (2002). Treatment of upper extremity spasticity in stroke patients by focal neuronal or neuromuscular blockade: a systematic review of the literature. Journal of Rehabilitation Medicine, 34(2), 51–61. https://doi.org/10.1080/165019702753557836
Binder-Markey, B. I., Murray, W. M., & Dewald, J. P. A. (2021). Passive Properties of the Wrist and Fingers Following Chronic Hemiparetic Stroke: Interlimb Comparisons in Persons With and Without a Clinical Treatment History That Includes Botulinum Neurotoxin. Frontiers in Neurology, 12. https://doi.org/10.3389/fneur.2021.687624
Malhotra, S., Pandyan, A., Day, C., Jones, P., & Hermens, H. (2009). Spasticity, an impairment that is poorly defined and poorly measured. Clinical Rehabilitation, 23(7), 651–658. https://doi.org/10.1177/0269215508101747
Figueiredo, S., & Zeltzer, L. (2011, July 13). Modified Ashworth Scale. Stroke Engine.
Singh, J. A., & Fitzgerald, P. M. (2010). Botulinum toxin for shoulder pain. Cochrane Database of Systematic Reviews. https://doi.org/10.1002/14651858.CD008271.pub2
Jia, S., Liu, Y., Shen, L., Liang, X., Xu, X., & Wei, Y. (2020). Botulinum Toxin Type A for Upper Limb Spasticity in Poststroke Patients: A Meta-analysis of Randomized Controlled Trials. Journal of Stroke and Cerebrovascular Diseases, 29(6), 104682. https://doi.org/10.1016/j.jstrokecerebrovasdis.2020.104682
Saikaley, M., Pauli, G., Iruthayarajah, J., & Mirkowski, M. (2018). Upper Extremity Interventions. Evidence-Based Review of Stroke Rehabilitation, 19.
Masakado, Y., Abo, M., Kondo, K., Saeki, S., Saitoh, E., Dekundy, A., Hanschmann, A., & Kaji, R. (2020). Efficacy and safety of incobotulinumtoxinA in post-stroke upper-limb spasticity in Japanese subjects: results from a randomized, double-blind, placebo-controlled study (J-PURE). Journal of Neurology, 267(7), 2029–2041. https://doi.org/10.1007/s00415-020-09777-5
Sun, L.-C., Chen, R., Fu, C., Chen, Y., Wu, Q., Chen, R., Lin, X., & Luo, S. (2019). Efficacy and Safety of Botulinum Toxin Type A for Limb Spasticity after Stroke: A Meta-Analysis of Randomized Controlled Trials. BioMed Research International, 2019, 1–17. https://doi.org/10.1155/2019/8329306
Andringa, A., van de Port, I., van Wegen, E., Ket, J., Meskers, C., & Kwakkel, G. (2019). Effectiveness of Botulinum Toxin Treatment for Upper Limb Spasticity Poststroke Over Different ICF Domains: A Systematic Review and Meta-Analysis. Archives of Physical Medicine and Rehabilitation, 100(9), 1703–1725. https://doi.org/10.1016/j.apmr.2019.01.016
Xie, H.-M., Guo, T.-T., Sun, X., Ge, H.-X., Chen, X.-D., Zhao, K.-J., & Zhang, L.-N. (2021). Effectiveness of Botulinum Toxin A in Treatment of Hemiplegic Shoulder Pain: A Systematic Review and Meta-analysis. Archives of Physical Medicine and Rehabilitation, 102(9), 1775–1787. https://doi.org/10.1016/j.apmr.2020.12.010
Rosales, R. L., Kong, K. H., Goh, K. J., Kumthornthip, W., Mok, V. C. T., Delgado-De Los Santos, M. M., Chua, K. S. G., Abdullah, S. J. bin F., Zakine, B., Maisonobe, P., Magis, A., & Wong, K. S. L. (2012). Botulinum Toxin Injection for Hypertonicity of the Upper Extremity Within 12 Weeks After Stroke. Neurorehabilitation and Neural Repair, 26(7), 812–821. https://doi.org/10.1177/1545968311430824
Maulet, T., Pouplin, S., Bensmail, D., Zory, R., Roche, N., & Bonnyaud, C. (2021). Self-rehabilitation combined with botulinum toxin to improve arm function in people with chronic stroke. A randomized controlled trial. Annals of Physical and Rehabilitation Medicine, 64(4), 101450. https://doi.org/10.1016/j.rehab.2020.10.004
Tan, B., & Jia, L. (2021). Ultrasound-Guided BoNT-A (Botulinum Toxin A) Injection Into the Subscapularis for Hemiplegic Shoulder Pain: A Randomized, Double-Blind, Placebo-Controlled Trial. Stroke, 52(12), 3759–3767. https://doi.org/10.1161/STROKEAHA.121.034049
Hung, J.-W., Yen, C.-L., Chang, K.-C., Chiang, W.-C., Chuang, I.-C., Pong, Y.-P., Wu, W.-C., & Wu, C.-Y. (2022). A Pilot Randomized Controlled Trial of Botulinum Toxin Treatment Combined with Robot-Assisted Therapy, Mirror Therapy, or Active Control Treatment in Patients with Spasticity Following Stroke. Toxins, 14(6), 415. https://doi.org/10.3390/toxins14060415
Nasb, M., Li, Z., S.A. Youssef, A., Dayoub, L., & Chen, H. (2019). Comparison of the effects of modified constraint-induced movement therapy and intensive conventional therapy with a botulinum-a toxin injection on upper limb motor function recovery in patients with stroke. Libyan Journal of Medicine, 14(1). https://doi.org/10.1080/19932820.2019.1609304
Rosales, R., Balcaitiene, J., Berard, H., Maisonobe, P., Goh, K., Kumthornthip, W., Mazlan, M., Latif, L., Delos Santos, M., Chotiyarnwong, C., Tanvijit, P., Nuez, O., & Kong, K. (2018). Early AbobotulinumtoxinA (Dysport®) in Post-Stroke Adult Upper Limb Spasticity: ONTIME Pilot Study. Toxins, 10(7), 253. https://doi.org/10.3390/toxins10070253
Gracies, J.-M., Bayle, N., Goldberg, S., & Simpson, D. M. (2014). Botulinum Toxin Type B in the Spastic Arm: A Randomized, Double-Blind, Placebo-Controlled, Preliminary Study. Archives of Physical Medicine and Rehabilitation, 95(7), 1303–1311. https://doi.org/10.1016/j.apmr.2014.03.016
Nasb, M., Shah, S. Z. A., Chen, H., Youssef, A. S., Li, Z., Dayoub, L., Noufal, A., Allam, A. E. S., Hassaniem, M., el Oumri, A. A., Chang, K.-V., Wu, W.-T., Rekatsina, M., Galluccio, F., AlKhrabsheh, A., Salti, A., & Varrassi, G. (2021). Constraint-Induced Movement Therapy Combined With Botulinum Toxin for Post-stroke Spasticity: A Systematic Review and Meta-Analysis. Cureus. https://doi.org/10.7759/cureus.17645
Lindsay, C., Ispoglou, S., Helliwell, B., Hicklin, D., Sturman, S., & Pandyan, A. (2021). Can the early use of botulinum toxin in post stroke spasticity reduce contracture development? A randomised controlled trial. Clinical Rehabilitation, 35(3), 399–409. https://doi.org/10.1177/0269215520963855
Marvulli, R., Mastromauro, L., Romanelli, E., Lopopolo, A., Dargenio, M., Fornarelli, F., Conte, E., Fiore, P., Megna, M., & Ianieri, G. (2016). How Botulinum Toxin Type A- Occupational Therapy (OT)-Functional Electrical Stimulation (FES) Modify Spasticity and Functional Recovery in Patients with Upper Limb Spasticity Post Stroke. Clinical Immunology, Endocrine & Metabolic Drugs, 3(1), 62–67. https://doi.org/10.2174/2212707003666160728143344
Simpson, D. M., Hallett, M., Ashman, E. J., Comella, C. L., Green, M. W., Gronseth, G. S., Armstrong, M. J., Gloss, D., Potrebic, S., Jankovic, J., Karp, B. P., Naumann, M., So, Y. T., & Yablon, S. A. (2016). Practice guideline update summary: Botulinum neurotoxin for the treatment of blepharospasm, cervical dystonia, adult spasticity, and headache. Neurology, 86(19), 1818–1826. https://doi.org/10.1212/WNL.0000000000002560
Zakin, E., & Simpson, D. (2018). Evidence on botulinum toxin in selected disorders. Toxicon, 147, 134–140. https://doi.org/10.1016/j.toxicon.2018.01.019
Do, K. H., Chun, M. H., Paik, N.-J., Park, Y. G., Lee, S.-U., Kim, M.-W., & Kim, D.-K. (2017). Safety and efficacy of letibotulinumtoxinA(BOTULAX®) in treatment of post stroke upper limb spasticity: a randomized, double blind, multi-center, phase III clinical trial. Clinical Rehabilitation, 31(9), 1179–1188. https://doi.org/10.1177/0269215516689331
Jagota, P., Kaewwilai, L., Boonrod, N., Singmaneesakulchai, S., Boonpang, K., Sringean, J., Jitkritsadakul, O., & Petchrutchatachart, S. (2016). Impact of Neu-botulinumtoxinA on the Severity and Quality of Life of Cervical Dystonia Patients. Tremor and Other Hyperkinetic Movements (New York, N.Y.), 6, 407. https://doi.org/10.7916/D8736R2H
Cheon, H. I., Jung, N., Won, C. H., Kim, B. J., & Lee, Y. W. (2019). Efficacy and Safety of Prabotulinumtoxin A and Onabotulinumtoxin A for Crowʼs Feet. Dermatologic Surgery, 45(12), 1610–1619. https://doi.org/10.1097/DSS.0000000000001920
Kutschenko, A., Weisemann, J., Kollewe, K., Fiedler, T., Alvermann, S., Böselt, S., Escher, C., Garde, N., Gingele, S., Kaehler, S.-B., Karatschai, R., Krüger, T. H. C., Sikorra, S., Tacik, P., Wegner, F., Wollmann, J., Bigalke, H., Wohlfarth, K., & Rummel, A. (2019). Botulinum neurotoxin serotype D – A potential treatment alternative for BoNT/A and B non-responding patients. Clinical Neurophysiology, 130(6), 1066–1073. https://doi.org/10.1016/j.clinph.2019.02.007
Santamato, A., Micello, M. F., Ranieri, M., Valeno, G., Albano, A., Baricich, A., Cisari, C., Intiso, D., Pilotto, A., Logroscino, G., & Panza, F. (2015). Employment of higher doses of botulinum toxin type A to reduce spasticity after stroke. Journal of the Neurological Sciences, 350(1–2), 1–6. https://doi.org/10.1016/j.jns.2015.01.033
Chiu, S. Y., Patel, B., Burns, M. R., Legacy, J., Wagle Shukla, A., Ramirez-Zamora, A., Deeb, W., & Malaty, I. A. (2020). High-dose Botulinum Toxin Therapy: Safety, Benefit, and Endurance of Efficacy. Tremor and Other Hyperkinetic Movements (New York, N.Y.), 10. https://doi.org/10.7916/tohm.v0.749
Teasell, R., & Hussein, N. (2018, March). Background Concepts in Stroke Rehabilitation. EBRSR.
Bakheit, A. M., Ward, C. D., & McLellan, D. L. (1997). Generalised botulism-like syndrome after intramuscular injections of botulinum toxin type A: a report of two cases. Journal of Neurology, Neurosurgery & Psychiatry, 62(2), 198–198. https://doi.org/10.1136/jnnp.62.2.198
Anandan, C., & Jankovic, J. (2021). Botulinum Toxin in Movement Disorders: An Update. Toxins, 13(1), 42. https://doi.org/10.3390/toxins13010042
Bellows, S., & Jankovic, J. (2019). Immunogenicity Associated with Botulinum Toxin Treatment. Toxins, 11(9), 491. https://doi.org/10.3390/toxins11090491
Ward, S. R., Minamoto, V. B., Suzuki, K. P., Hulst, J. B., Bremner, S. N., & Lieber, R. L. (2018). Recovery of rat muscle size but not function more than 1 year after a single botulinum toxin injection. Muscle & Nerve, 57(3), 435–441. https://doi.org/10.1002/mus.25707
Ateş, F., & Yucesoy, C. A. (2014). Effects of botulinum toxin type A on non-injected bi-articular muscle include a narrower length range of force exertion and increased passive force. Muscle & Nerve, 49(6), 866–878. https://doi.org/10.1002/mus.23993
Thacker, B. E., Tomiya, A., Hulst, J. B., Suzuki, K. P., Bremner, S. N., Gastwirt, R. F., Greaser, M. L., Lieber, R. L., & Ward, S. R. (2012). Passive mechanical properties and related proteins change with botulinum neurotoxin A injection of normal skeletal muscle. Journal of Orthopaedic Research, 30(3), 497–502. https://doi.org/10.1002/jor.21533
Pingel, J., Wienecke, J., Lorentzen, J., & Nielsen, J. B. (2016). Botulinum toxin injection causes hyper-reflexia and increased muscle stiffness of the triceps surae muscle in the rat. Journal of Neurophysiology, 116(6), 2615–2623. https://doi.org/10.1152/jn.00452.2016
Mathevon, L., Michel, F., Decavel, P., Fernandez, B., Parratte, B., & Calmels, P. (2015). Muscle structure and stiffness assessment after botulinum toxin type A injection. A systematic review. Annals of Physical and Rehabilitation Medicine, 58(6), 343–350. https://doi.org/10.1016/j.rehab.2015.06.002
Botox Label. (2011). In FDA. Allergan, Inc.
Newman, W. J., Davis, T. L., Padaliya, B. B., Covington, C. D., Gill, C. E., Abramovitch, A. I., & Charles, P. D. (2004). Botulinum toxin type A therapy during pregnancy. Movement Disorders, 19(11), 1384–1385. https://doi.org/10.1002/mds.20205
Morgan, J. C. (2006). Botulinum toxin A during pregnancy: a survey of treating physicians. Journal of Neurology, Neurosurgery & Psychiatry, 77(1), 117–119. https://doi.org/10.1136/jnnp.2005.063792
Vartanian, A. J., & Dayan, S. H. (2003). Complications of botulinum toxin A use in facial rejuvenation. Facial Plastic Surgery Clinics of North America, 11(4), 483–492. https://doi.org/10.1016/S1064-7406(03)00070-1
Careta, M. F., Delgado, L., & Patriota, R. (2015). Report of Allergic Reaction After Application of Botulinum Toxin. Aesthetic Surgery Journal, 35(5), NP102-5. https://doi.org/10.1093/asj/sju105
Rosenfield, L. K., Kardassakis, D. G., Tsia, K. A., & Stayner, G. (2014). The First Case Report of a Systemic Allergy to OnabotulinumtoxinA (Botox) in a Healthy Patient. Aesthetic Surgery Journal, 34(5), 766–768. https://doi.org/10.1177/1090820X14532648
Reitblat, O., Lerman, T. T., & Reitblat, T. (2018). AB1349 Safety and effectiveness of cosmetic minimaly invasive procedures among patients with systemic autoimmune disease. Annals of the Rheumatic Diseases, 77(Suppl 2), 1763. https://doi.org/10.1136/annrheumdis-2018-eular.1093
Huang, W., Foster, J. A., & Rogachefsky, A. S. (2000). Pharmacology of botulinum toxin. Journal of the American Academy of Dermatology, 43(2), 249–259. https://doi.org/10.1067/mjd.2000.105567
Ballester, B. R., Maier, M., San Segundo Mozo, R. M., Castañeda, V., Duff, A., & M. J. Verschure, P. F. (2016). Counteracting learned non-use in chronic stroke patients with reinforcement-induced movement therapy. Journal of NeuroEngineering and Rehabilitation, 13(1), 74. https://doi.org/10.1186/s12984-016-0178-x
Taub, E., Uswatte, G., Mark, V. W., Morris, D. M., Barman, J., Bowman, M. H., Bryson, C., Delgado, A., & Bishop-McKay, S. (2013). Method for Enhancing Real-World Use of a More Affected Arm in Chronic Stroke. Stroke, 44(5), 1383–1388. https://doi.org/10.1161/STROKEAHA.111.000559
Allred, R. P., Kim, S. Y., & Jones, T. A. (2014). Use it and/or lose it—experience effects on brain remodeling across time after stroke. Frontiers in Human Neuroscience, 8. https://doi.org/10.3389/fnhum.2014.00379
Abdullahi, A., Candan, S. A., Soysal Tomruk, M., Yakasai, A. M., Truijen, S., & Saeys, W. (2021). Constraint-induced movement therapy protocols using the number of repetitions of task practice: a systematic review of feasibility and effects. Neurological Sciences, 42(7), 2695–2703. https://doi.org/10.1007/s10072-021-05267-2
Corbetta, D., Sirtori, V., Castellini, G., Moja, L., & Gatti, R. (2015). Constraint-induced movement therapy for upper extremities in people with stroke. Cochrane Database of Systematic Reviews, 2017(9). https://doi.org/10.1002/14651858.CD004433.pub3
Whitcup, S. M. (2019). The History of Botulinum Toxins in Medicine: A Thousand Year Journey (pp. 3–10). https://doi.org/10.1007/164_2019_271
Cao, M., & Li, X. (2021). Effectiveness of modified constraint-induced movement therapy for upper limb function intervention following stroke: A brief review. Sports Medicine and Health Science, 3(3), 134–137. https://doi.org/10.1016/j.smhs.2021.08.001
Batool, S., Soomro, N., Amjad, F., & Fauz, R. (n.d.). To compare the effectiveness of constraint induced movement therapy versus motor relearning programme to improve motor function of hemiplegic upper extremity after stroke. Pakistan Journal of Medical Sciences, 31(5), 1167–1171. https://doi.org/10.12669/pjms.315.7910
Viana, R., & Teasell, R. (2012). Barriers to the Implementation of Constraint-Induced Movement Therapy Into Practice. Topics in Stroke Rehabilitation, 19(2), 104–114. https://doi.org/10.1310/tsr1902-104
Wang, D., Xiang, J., He, Y., Yuan, M., Dong, L., Ye, Z., & Mao, W. (2022). The Mechanism and Clinical Application of Constraint-Induced Movement Therapy in Stroke Rehabilitation. Frontiers in Behavioral Neuroscience, 16. https://doi.org/10.3389/fnbeh.2022.828599
Jokinen, H., Melkas, S., Ylikoski, R., Pohjasvaara, T., Kaste, M., Erkinjuntti, T., & Hietanen, M. (2015). Post-stroke cognitive impairment is common even after successful clinical recovery. European Journal of Neurology, 22(9), 1288–1294. https://doi.org/10.1111/ene.12743
Delgado, D. A., Lambert, B. S., Boutris, N., McCulloch, P. C., Robbins, A. B., Moreno, M. R., & Harris, J. D. (2018). Validation of Digital Visual Analog Scale Pain Scoring With a Traditional Paper-based Visual Analog Scale in Adults. JAAOS: Global Research and Reviews, 2(3), e088. https://doi.org/10.5435/JAAOSGlobal-D-17-00088
McDermott, A. (2012, June 19). Disabilities of the Arm, Shoulder and Hand (DASH). Stroke Engine.
Published
How to Cite
Issue
Section
Copyright (c) 2023 Audrey Tsai; Jane Sullivan
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Copyright holder(s) granted JSR a perpetual, non-exclusive license to distriute & display this article.
